Project Grant HT94252410309
Award Date 9/1/24
Completion Date 8/31/26
Dollars Obligated $408K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Similar Awards
- The University of British Columbia (UBC), through its Research Services division, was awarded a $1,156,654 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports research aimed at neuromodulation techniques to improve bladder function in a large animal model of spinal cord injury. The research will be conducted over a period of 3 years from September 30, 2024 to September 29, 2027. As a prominent...
- The University of British Columbia (UBC) received a $1,731,421.95 Project Grant award from the Defense Health Agency under the Military Medical Research and Development Program (CFDA 12.420) to provide advanced physiologic monitoring at the site of spinal cord injury. The 3-year project, with a start date of September 30, 2023, will focus on transforming healthcare for Service Members and the public through innovative and impactful research into medical solutions for the battlefield. As the...
- The University of British Columbia was awarded a $2,498,328 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct research on using blood biomarkers to improve diagnosis of brain injury and assess dementia risk in survivors of intimate partner violence. The 4-year grant, awarded on June 1, 2024, will enable UBC researchers to leverage their expertise in biomedical research, clinical trials, and data analysis to...
- The University of British Columbia (UBC) was awarded a $561,584 project grant by the Defense Health Agency to conduct research on the measurement and impact of body composition using CT imaging in patients with germ cell tumors undergoing chemotherapy. This grant is funded under the Military Medical Research and Development Program (CFDA 12.420), which supports biomedical research to transform healthcare for service members and the public through innovative and impactful research, including...
- The University of British Columbia was awarded a $1,868,800 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) with a performance period of September 1, 2025 to August 31, 2028. The grant will fund research on the effect of cardiocentric hemodynamic management on cardiovascular outcomes in individuals with acute cervical spinal cord injuries. This project aims to develop novel diagnostic tools, therapeutic interventions, and clinical...
- The University of British Columbia (UBC) received a $507,035 Project Grant award from the Defense Health Agency under the Military Medical Research and Development Program (CFDA 12.420). The grant, awarded on September 1, 2023, will fund research for "The Ovarian Cancer Observatory: Prevention, Impact, and Learning from Opportunistic Salpingectomy" over a 4-year period through August 31, 2027. As the prime grantee, UBC will leverage its expertise in medical research and data analysis...
- Federal Project Grant Award Summary The University of British Columbia received a $426,154 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2027. The grant supports research investigating ASCL1-driven immunological landscapes in neuroendocrine prostate cancer, with the objective of enhancing immunotherapy efficacy. This research falls within the DHA's broader mission to...
- The University of British Columbia (UBC) was awarded a $525,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development Program (CFDA 12.420) to engineer an effective combination therapy involving car T cells and regulatory T cells to control vascular composite allograft (VCA) rejection. The 3-year project, running from August 1, 2023 to July 31, 2026, will focus on developing innovative medical solutions to address transplant rejection issues for service...
- Federal Grant Award Summary The University of British Columbia received a $5.74M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2029. The award supports translational research investigating the pathophysiology of traumatic brain injury (TBI) and nonfatal strangulation within the context of intimate partner violence. This research will advance understanding of the...
- The federal Project Grant award of $1,477,615.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will fund comparative transcriptomic and proteomic profiling of full-length androgen receptor (AR) and AR-V7 splice variant condensates in prostate cancer at the University of British Columbia. The research, to be conducted from April 15, 2025 to April 14, 2028, aims to transform healthcare for military service members, veterans, and the broader public...